01 3Staybla
Main Therapeutic Indication : Renal Disorders
Currency : USD
2017 Revenue in Millions : 42
2016 Revenue in Millions : 47
Growth (%) : -10
Main Therapeutic Indication : Renal Disorders
Currency : USD
2018 Revenue in Millions : 33
2017 Revenue in Millions : 40
Growth (%) : -16%
Main Therapeutic Indication : Nephrology
Currency : USD
2019 Revenue in Millions : 31
2018 Revenue in Millions : 34
Growth (%) : -11
LOOKING FOR A SUPPLIER?
